Pharmacological characteristics and clinical outcomes of Rimegepant (Nurtec<sup>®</sup> ODT), an oral CGRP receptor antagonist for the acute treatment and prevention of migraine

Authors

Institutions

Publication Details

Journal
Folia Pharmacologica Japonica
Published
2026-06-30
DOI
https://doi.org/10.1254/fpj.26050
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacological characteristics and clinical outcomes of Rimegepant (Nurtec® ODT), an oral CGRP receptor antagonist for the acute treatment and prevention of migraine

Masahiro Iijima, Tomofumi Ishikawa, Beini Shi, Saori Morota et al.
Folia Pharmacologica Japonica
Migraine and Headache Studies
article

Pharmacological characteristics and clinical outcomes of Rimegepant (Nurtec® ODT), an oral CGRP receptor antagonist for the acute treatment and prevention of migraine

Masahiro Iijima, Tomofumi Ishikawa, Beini Shi, Saori Morota, Yinhua Li
article en

Abstract

No abstract available for this paper.
Folia Pharmacologica JaponicaVol. 161(4)
Pfizer (Japan) (JP)
Good health and well-being
Openalex Percentile: Top 7%
Migraine and Headache Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.